Topical fibroblast growth factor‐2 for treatment of chronic tympanic membrane perforations

OBJECTIVE: To determine the efficacy of fibroblast growth factor‐2 (FGF‐2) in treating chronic nonhealing tympanic membrane (TM) perforations. METHOD: Double‐blinded, randomized placebo controlled phase 2 clinical trial for patients with chronic TM perforations of more than 3 months duration with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Felipe, Shu, Edina, Lee, Daniel J., Jung, David H., Quesnel, Alicia M., Stankovic, Konstantina M., Abdul‐Aziz, Dunia E., Bay, Camden P., Quinkert, Amy, Welling, D. Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Comprehensive (General) Otolaryngology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444771/
https://www.ncbi.nlm.nih.gov/pubmed/32864435
http://dx.doi.org/10.1002/lio2.395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444771/
https://www.ncbi.nlm.nih.gov/pubmed/32864435
http://dx.doi.org/10.1002/lio2.395

Ejemplares similares